Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression

Addiction Biology

Volumn 16, Issue 1, 2011, Pages 7-19

  Jaehne, Emily J ^a   Majumder, Irina ^a   Salem, Abdallah ^a   Irvine, Rodney J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Depression model; ecstasy; Flinders Sensitive Line; heart rate; MDMA; thermoregulation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; SEROTONIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BRAIN; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFECT; HYPERTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THERMOREGULATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; AROUSAL; BODY TEMPERATURE REGULATION; BRAIN; CEREBRAL CORTEX; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; HALLUCINOGENS; HEART RATE; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 78649940332     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2009.00196.x     Document Type: Article

References (65)

1. Alves E, Binienda Z, Carvalho F, Alves CJ, Fernandes E, De Lourdes Bastos M, Tavares MA, Summavielle T, (2009) Acetyl-l-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain. Neuroscience 158: 514-523.
2. Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA, (2009) Effects of dose and route of administration on pharmacokinetics of ({+/-})-3,4-methylenedioxymethamphetamine (MDMA) in the rat. Drug Metab Dispos 37: 2163-2170.
3. Bexis S, Phillis BD, Ong J, White JM, Irvine RJ, (2004) Baclofen prevents MDMA-induced rise in core body temperature in rats. Drug Alcohol Depend 74: 89-96.
4. Blessing WW, Seaman B, (2003) 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats. Neuroscience 117: 939-948.
5. Blessing WW, Seaman B, Pedersen NP, Ootsuka Y, (2003) Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. J Neurosci 23: 6385-6391.
6. Callaghan PD, Farrand K, Salem A, Hughes P, Daws LC, Irvine RJ, (2006) Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. Eur J Pharmacol 546: 74-81.
7. Cappon GD, Morford LL, Vorhees CV, (1998) Enhancement of cocaine-induced hyperthermia fails to elicit neurotoxicity. Neurotoxicol Teratol 20: 531-535.
8. Chambers JB, Williams TD, Nakamura A, Henderson RP, Overton JM, Rashotte ME, (2000) Cardiovascular and metabolic responses of hypertensive and normotensive rats to one week of cold exposure. Am J Physiol Regul Integr Comp Physiol 279: R1486-R1494.
9. Crocker AD, Overstreet DH, (1991) Dopamine sensitivity in rats selectively bred for increases in cholinergic function. Pharmacol Biochem Behav 38: 105-108.
10. Dremencov E, Newman ME, Kinor N, Blatman-Jan G, Schindler CJ, Overstreet DH, Yadid G, (2005) Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment. Neuropharmacology 48: 34-42.
11. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G, (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). J Neurosci 15: 5476-5485.
12. Florez-Duquet M, Peloso E, Satinoff E, (2001) Fever and behavioral thermoregulation in young and old rats. Am J Physiol Regul Integr Comp Physiol 280: R1457-R1461.
13. Gordon CJ, (1987) Relationship between preferred ambient temperature and autonomic thermoregulatory function in rat. Am J Physiol 252: R1130-R1137.
14. Gordon CJ, (1990) Thermal biology of the laboratory rat. Physiol Behav 47: 963-991.
15. Gowing LR, Henry-Edwards SM, Irvine RJ, Ali RL, (2002) The health effects of ecstasy: a literature review. Drug Alcohol Rev 21: 53-63.
16. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI, (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 55: 463-508.
17. Green AR, O'Shea E, Colado MI, (2004) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500: 3-13.
18. Guillot C, Greenway D, (2006) Recreational ecstasy use and depression. J Psychopharmacol 20: 411-416.
19. Hamida SB, Tracqui A, De Vasconcelos AP, Szwarc E, Lazarus C, Kelche C, Jones BC, Cassel JC, (2009) Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA. Int J Neuropsychopharmacol 12: 749-759.
20. Hasegawa S, Nishi K, Watanabe A, Overstreet DH, Diksic M, (2006) Brain 5-HT synthesis in the Flinders sensitive line rat model of depression: an autoradiographic study. Neurochem Int 48: 358-366.
21. Hildreth CM, Padley JR, Pilowsky PM, Goodchild AK, (2008) Impaired serotonergic regulation of heart rate may underlie reduced baroreflex sensitivity in an animal model of depression. Am J Physiol Heart Circ Physiol 294: H474-H480.
22. Irvine RJ, White J, Chan R, (1997) The influence of restraint on blood pressure in the rat. J Pharmacol Toxicol Methods 38: 157-162.
23. Jaehne EJ, Salem A, Irvine RJ, (2005) Effects of 3,4- methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation. Pharmacol Biochem Behav 81: 485-496.
24. Jaehne EJ, Salem A, Irvine RJ, (2007) Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia. Psychopharmacology 194: 41-52.
25. Jaehne EJ, Salem A, Irvine RJ, (2008) The effect of long term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes. Psychopharmacology 201: 161-170.
26. Janowsky DS, Overstreet DH, Nurnberger JI Jr, (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54: 335-344.
27. Kita T, Wagner GC, Nakashima T, (2003) Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92: 178-195.
28. Law MY, Moody DE, (1994) Urinary excretion of amphetamine and 4′-hydroxyamphetamine by Sprague Dawley and dark Agouti rats. Life Sci 54: 1073-1079.
29. Lieb R, Schuetz CG, Pfister H, Von Sydow K, Wittchen H, (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68: 195-207.
30. Lyles J, Cadet JL, (2003) Methylenedioxymethamphetamine (MDMA, ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Brain Res Rev 42: 155-168.
31. Malberg JE, Sabol KE, Seiden LS, (1996) Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278: 258-267.
32. Malberg JE, Seiden LS, (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18: 5086-5094.
33. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA, (1998) Positron emission tomographic evidence of toxic effect of MDMA ('ecstasy') on brain serotonin neurons in human beings. Lancet 352: 1433-1437.
34. McDougall SJ, Lawrence AJ, Widdop RE, (2005) Differential cardiovascular responses to stressors in hypertensive and normotensive rats. Exp Physiol 90: 141-150.
35. Matthews K, Baldo BA, Markou A, Lown O, Overstreet DH, Koob GF, (1996) Rewarding electrical brain stimulation: similar thresholds for Flinders sensitive line hypercholinergic and Flinders resistant line hypocholinergic rats. Physiol Behav 59: 1155-1162.
36. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR, (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135: 170-180.
37. Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH, (2001) Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12: 4121-4125.
38. Michel RE, Rege AB, George WJ, (1993) High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues. J Neurosci Methods 50: 61-66.
39. Monks TJ, Jones DC, Bai F, Lau SS, (2004) The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Ther Drug Monit 26: 132-136.
40. Morishima MS, Gale CC, (1972) Relationship of blood pressure and heart rate to body temperature in baboons. Am J Physiol 223: 387-395.
41. Ootsuka Y, Blessing WW, (2003) 5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits. J Physiol 552: 303-314.
42. Overstreet DH, (2002) Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 32: 335-348.
43. Overstreet DH, Daws LC, Schiller GD, Orbach J, Janowsky DS, (1998) Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol Biochem Behav 59: 777-785.
44. Overstreet DH, Friedman E, Mathe AA, Yadid G, (2005) The Flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29: 739-759.
45. Overstreet DH, Rezvani AH, Janowsky DS, (1990) Increased hypothermic responses to ethanol in rats selectively bred for cholinergic supersensitivity. Alcohol Alcohol 25: 59-65.
46. Overstreet DH, Russell RW, (1982) Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology 78: 150-155.
47. Overstreet DH, Russell RW, Helps SC, Messenger M, (1979) Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology 65: 15-20.
48. Parrott AC, (2002) Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71: 837-844.
49. Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB, (2006) Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Hum Psychopharmacol 21: 285-298.
50. Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL, (1992) Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse. Lancet 339: 677-678.
51. Shayit M, Yadid G, Overstreet DH, Weller A, (2003) 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression. Brain Res 980: 100-108.
52. Shiromani PJ, Klemfuss H, Lucero S, Overstreet DH, (1991) Diurnal rhythm of core body temperature is phase advanced in a rodent model of depression. Biol Psychiatry 29: 923-930.
53. Soar K, Turner JJ, Parrott AC, (2001) Psychiatric disorders in ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history. Hum Psychopharmacol 16: 641-645.
54. United Nations (2003) United Nations Ecstasy and Amphetamines Global Survey. New York: United Nations Publications.
55. United Nations (2008) World Drug Report 2008. New York: United Nations Office on Drugs and Crime.
56. Upreti VV, Eddington ND, (2008) Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) in rat. J Pharm Sci 97: 1593-1605.
57. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN, (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377-382.
58. Wallis E, Overstreet DH, Crocker AD, (1988) Selective breeding for increased cholinergic function: increased serotonergic sensitivity. Pharmacol Biochem Behav 31: 345-350.
59. Wang X, Baumann MH, Xu H, Rothman RB, (2004) 3,4- methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53: 240-248.
60. Williamson S, Gossop M, Powis B, Griffiths P, Fountain J, Strang J, (1997) Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend 44: 87-94.
61. Yadid G, Overstreet DH, Zangen A, (2001) Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression. Brain Res 896: 43-47.
62. Zambello E, Jimenez-Vasquez PA, El Khoury A, Mathe AA, Caberlotto L, (2008) Acute stress differentially affects corticotropin-releasing hormone mRNA expression in the central amygdala of the 'depressed' flinders sensitive line and the control flinders resistant line rats. Prog Neuropsychopharmacol Biol Psychiatry 32: 651-661.
63. Zangen A, Nakash R, Overstreet DH, Yadid G, (2001) Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology 155: 434-439.
64. Zangen A, Overstreet DH, Yadid G, (1997) High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 69: 2477-2483.
65. Zangen A, Overstreet DH, Yadid G, (1999) Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment. Brain Res 824: 243-250.